Reduction of PARP1 gene expression in lung tissue due to swimming exercise in an animal model of lung cancer with benzopyrene
الموضوعات : Journal of Physical Activity and Hormones
Hediyeh Bahreman
1
,
Mehrzad Moghadasi
2
,
Seyed Ali Hosseini
3
1 - Department of Physical Education and Sports Medicine, Sh.C., Islamic Azad University, Shiraz, Iran
2 - Department of Physical Education and Sports Medicine, Sh.C., Islamic Azad University, Shiraz, Iran
3 - Department of Physical Education and Sports Medicine, Marv.C., Islamic Azad University, Marvdasht, Iran
الکلمات المفتاحية: Swimming, PARP1, Body Composition, Lung Cancer, Benzopyrene,
ملخص المقالة :
Introduction: Lung cancer, the second most common cancer in the world, is associated with impaired lung function and physical disorders. Although the role of exercise on the health of cancer patients has been reported, the effect of exercise on the improvement of this type of cancer is not clear. Given the limited information regarding the effect of exercise on oncogenes associated with lung cancer, the present study aimed to investigate the effect of a swimming exercise period on PARP1 gene expression in lung tissue of an animal model of lung cancer with benzopyrene (BZP).
Material & Methods: In this experimental study, 12 BALB/c mice, 8-10 weeks old, weighing 18-22 grams were divided into lung cancer (LC) and lung cancer + swimming exercise (SE) groups. Additionally, 6 mice were considered as healthy control (HC) group. BZP was administered for lung cancer induction at a dose of a dose of 100 mg/kg for two weeks. Mice in the SE group performed swimming exercise with 2% of their body weight for 10 weeks, three sessions per week, each session lasting 5-38 minutes. PARP1 gene expression in lung tissue was measured 48 hours after the last training session using real-time PCR method. Data were analyzed using one-way ANOVA with Tukey's post hoc test in SPSS software version 22 and a significance level of 0.05.
Results: In the LC group, post-test weight and visceral fat weight were significantly lower and PARP1 expression was significantly higher than in the HC group (P=0.001). Study data revealed that in the SE group, post-test weight (P=0.001) and visceral fat weight (P=0.03) were significantly higher and PARP1 expression (P=0.016) were significantly lower than in the LC group.
Conclusion: Generally, it seems that although lung cancer induction increases PARP1 gene expression in lung tissue, regular swimming exercise can lead to a decrease in PARP1 and possibly improve lung cancer. Given the limitations of the data, more studies are needed in this field.
1. Sung H, Ferlay J, Siegel RL, Jemal A. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-49. doi: 10.3322/caac.21660
2. Lu T, Yang X, Huang Y. Trends in the incidence, treatment, and survival of patients with lung cancer in the last four decades. Cancer Manag Res. 2019;11:943-53. doi: 10.2147/CMAR.S187317
3. Li Y, Yan B, He S. Advances and challenges in the treatment of lung cancer. Biomed Pharmacother. 2023;169:115891. doi: 10.1016/j.biopha.2023.115891
4. Li C, Lei S, Ding L. Global burden and trends of lung cancer incidence and mortality. Chin Med J (Engl). 2023;136(13):1583-90. doi: 10.1097/CM9.0000000000002526
5. Leiter A, Veluswamy RR, Wisnivesky JP. The global burden of lung cancer: current status and future trends. Nat Rev Clin Oncol. 2023;20(9):624-39. doi: 10.1038/s41571-023-00798-3
6. Govindan R, Page N, Morgensztern D, Read W, Tierney R, Vlahiotis A, et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol. 2006;24(28):4539-44. doi: 10.1200/JCO.2005.04.4859
7. Hegmann KT, Fraser AM, Keaney RP. The effect of age at smoking initiation on lung cancer risk. Epidemiology. 1993;4(5):444-8. doi: 10.1097/00001648-199309000-00010
8. Ebbert JO, Yang P, Vachon CM, Vierkant RA, Cerhan JR, Folsom AR, et al. Lung cancer risk reduction after smoking cessation: observations from a prospective cohort of women. J Clin Oncol. 2003;21(5):921-6. doi: 10.1200/JCO.2003.05.085
9. Bruce N, Dherani M, Liu R, Hosgood HD 3rd, Sapkota A, Smith KR, et al. Does household use of biomass fuel cause lung cancer? A systematic review and evaluation of the evidence for the GBD 2010 study. Thorax. 2015;70(5):433-41. doi: 10.1136/thoraxjnl-2014-206625
10. Turner MC, Krewski D, Chen Y, Pope CA 3rd, Gapstur SM, Thun MJ. Radon and lung cancer in the American Cancer Society cohort. Cancer Epidemiol Biomarkers Prev. 2011;20(3):438-48. doi: 10.1158/1055-9965.EPI-10-1153
11. Zhou J, Xu Y, Liu J, Feng L, Yu J, Chen D. Global burden of lung cancer in 2022 and projections to 2050: incidence and mortality estimates from GLOBOCAN. Cancer Epidemiol. 2024;93:102693. doi: 10.1016/j.canep.2024.102693
12. Gazdar AF, Bunn PA, Minna JD. Small-cell lung cancer: what we know, what we need to know and the path forward. Nat Rev Cancer. 2017;17(12):725-37. doi: 10.1038/nrc.2017.87
13. Kim C, Giaccone G. Precision oncology in non-small-cell lung cancer: opportunities and challenges. Nat Rev Clin Oncol. 2018;15(6):348-9. doi: 10.1038/s41571-018-0008-0
14. Pavan A, Attili I, Pasello G, Guarneri V, Conte PF, Bonanno L. Immunotherapy in small-cell lung cancer: from molecular promises to clinical challenges. J Immunother Cancer. 2019;7(1):205. doi: 10.1186/s40425-019-0699-1
15. Powell SN, Bindra RS. Targeting the DNA damage response for cancer therapy. DNA Repair (Amst). 2009;8(9):1153-65. doi: 10.1016/j.dnarep.2009.04.011
16. Bouwman P, Jonkers J. The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistance. Nat Rev Cancer. 2012;12(9):587-98. doi: 10.1038/nrc3342
17. Amé JC, Spenlehauer C, de Murcia G. The PARP superfamily. Bioessays. 2004;26(8):882-93. doi: 10.1002/bies.20085
18. Curtin NJ, Szabo C. Poly(ADP-ribose) polymerase inhibition: past, present and future. Nat Rev Drug Discov. 2020;19(10):711-36. doi: 10.1038/s41573-020-0076-6
19. Toohey K, Mizrahi D, Hart NH, Singh B, Lopez P, Hunter M, et al. Exercise in cancer care for people with lung cancer: a narrative synthesis. J Sci Med Sport. 2024;28(1):16-25. doi: 10.1016/j.jsams.2024.09.008
20. Zhou N, Ripley-Gonzalez JW, Zhang W, Xie K, You B, Shen Y, et al. Preoperative exercise training decreases complications of minimally invasive lung cancer surgery: a randomized controlled trial. J Thorac Cardiovasc Surg. 2025;169(2):516-28. doi: 10.1016/j.jtcvs.2024.07.042
21. Kurgan N, Tsakiridis E, Kouvelioti R, Moore J, Klentrou P, Tsiani E. Inhibition of human lung cancer cell proliferation and survival by post-exercise serum is associated with the inhibition of Akt, mTOR, p70 S6K, and Erk1/2. Cancers (Basel). 2017;9(5):46. doi: 10.3390/cancers9050046
22. Mirdar Harijani S, Musavi N. The effect of 12 weeks of submaximal swimming training on immunoreactivity of Ras and Raf-1 in lung epithelial cells of Wistar rats exposed to carcinogen NN. Res Sport Med Technol. 2020;18(19):113-26.
23. Abekova A, Islamov R. ChemoProtective effects of new iodine coordinated compound in benzo [a] pyrene-induced lung cancer in BALB/c mice. In: BIO Web of Conferences. EDP Sciences; 2024. Vol. 100, p. 03001. doi: 10.1051/bioconf/202410003001
24. Hu X, Geetha RV, Surapaneni KM, Veeraraghavan VP, Chinnathambi A, Alahmadi TA, et al. Lung cancer induced by Benzo(A)Pyrene: ChemoProtective effect of sinapic acid in Swiss albino mice. Saudi J Biol Sci. 2021;28(12):7125-33. doi: 10.1016/j.sjbs.2021.08.001
25. Mendes JL, Ferreira RQ, Mata I, Barreira JV, Rodrigues YC, Dias DS, et al. Body composition analysis in metastatic non-small-cell lung cancer: depicting sarcopenia in Portuguese tertiary care. Cancers (Basel). 2025;17(3):539. doi: 10.3390/cancers17030539
26. Al-Sawaf O, Weiss J, Skrzypski M, Lam JM, Karasaki T, Zambrana F, et al. Body composition and lung cancer-associated cachexia in TRACERx. Nat Med. 2023;29(4):846-58. doi: 10.1038/s41591-023-02232-8
27. Snoke DB, Atwood GS, Bellefleur ER, Stokes AM, Toth MJ. Body composition alterations in patients with lung cancer. Am J Physiol Cell Physiol. 2025;328(3):C872-86. doi: 10.1152/ajpcell.00462.2024
28. Chaunzwa TL, Qian JM, Li Q, Ricciuti B, Nuernberg L, Johnson JW, et al. Body composition in advanced non-small cell lung cancer treated with immunotherapy. JAMA Oncol. 2024;10(6):773-83. doi: 10.1001/jamaoncol.2024.0119
29. Vedire Y, Kalvapudi S, Yendamuri S. Obesity and lung cancer—a narrative review. J Thorac Dis. 2023;15(5):2806-23. doi: 10.21037/jtd-22-1299
30. Roggero CM, Ghosh AB, Devineni A, Ma S, Blatt E, Raj GV, et al. CDK4/6 inhibitors promote PARP1 degradation and synergize with PARP inhibitors in non-small cell lung cancer. Transl Oncol. 2025;52:102231. doi: 10.1016/j.tranon.2024.102231
31. Bastos IM, Rebelo S, Silva VL. A review of poly(ADP-ribose) polymerase-1 (PARP1) role and its inhibitors bearing pyrazole or indazole core for cancer therapy. Biochem Pharmacol. 2024;221:116045. doi: 10.1016/j.bcp.2024.116045
32. Tong J, Chen B, Volpi T, Li Y, Ellison PA, Cai Z. Current advances in PARP1-targeted theranostics. J Labelled Comp Radiopharm. 2025;68(1-2):e4135. doi: 10.1002/jlcr.4135
33. Cobley JN, Sakellariou GK, Murray S, Waldron S, Gregson W, Burniston JG, et al. Lifelong endurance training attenuates age-related genotoxic stress in human skeletal muscle. Longev Healthspan. 2013;2:11. doi: 10.1186/2046-2395-2-11
34. Moreno-Villanueva M, Kramer A, Hammes T, Venegas-Carro M, Thumm P, Bürkle A, et al. Influence of acute exercise on DNA repair and PARP activity before and after irradiation in lymphocytes from trained and untrained individuals. Int J Mol Sci. 2019;20(12):2999. doi: 10.3390/ijms20122999
35. Radák Z, Naito H, Kaneko T, Tahara S, Nakamoto H, Takahashi R, et al. Exercise training decreases DNA damage and increases DNA repair and resistance against oxidative stress of proteins in aged rat skeletal muscle. Pflugers Arch. 2002;445(2):273-8. doi: 10.1007/s00424-002-0911-6
